TReatment for ImmUne Mediated PathopHysiology
TReatment for ImmUne Mediated PathopHysiology
Active, not recruiting · NCT04862221 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TReatment for ImmUne Mediated PathopHysiology | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, acute liver failure, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-12 | NCT04862221 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | 76 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.